Staging Of Melanoma

When a melanoma has been diagnosed, the pathology report provides information to determine the "stage” of the disease.

The prognosis of melanoma and the treatment options available depending on the stage at which the cancer is diagnosed.

One of the most common areas of confusion is the difference between the levels of melanoma and the staging of melanoma. The level of melanoma relates to the depth of the melanoma in the skin and the staging of melanoma refers to how limited or advanced the melanoma is at the time of diagnosis.

The stages of melanoma are determined by reviewing different factors including:

Breslow Depth

Tumour depth or thickness is measured in millimetres by a pathologist using a microscope. This is referred to as the ‘Breslow Depth’. The thicker the tumour, the greater the chance it might have metastasised (spread) to regional lymph nodes or distant sites. Thinner melanomas have a better prognosis.

  • Less than 1mm: Thin melanoma
  • 1-4mm: Intermediate melanoma
  • Greater than 4mm: Thick melanoma

The tumour depth was traditionally described using a ‘Clark level’ to indicate the number of layers of skin penetrated by the melanoma. The Clark level is a number from I-V with V being the deepest penetration of the skin.  The usage of Clark levels has been replaced by the updated melanoma staging system which uses more reliably predictive features such as ulceration, mitotic count and Breslow depth.  Clark levels are discussed further in the Glossary.

Tumour Ulceration

Ulceration of a skin tumour means that the epidermis (or top layer of the skin) that covers the melanoma is not intact. Ulceration may not be seen with the naked eye. Ulcerated melanomas pose a greater risk for metastatic progression.

Number of metastatic lymph nodes involved

If the melanoma has spread to the lymph nodes the risk of spread to other parts of the body is higher. The greater the number of lymph nodes containing melanoma, the less favourable the prognosis.

A sentinel node biopsy is a technique used to determine whether melanoma cells have spread to lymph nodes at the time of diagnosis of the skin primary lesion. The procedure involves the injection of a radioactive tracer by a radiologist (in the radiology department), to show where the site and lymph node where the lymph fluid from the skin at the primary melanoma will flow. Afterwards, at the same time as the extra surgery for the primary melanoma, a blue dye is injected around the site of the primary lesion. Using the guide from the radiologist a surgeon looks for the first lymph node to take up the dye. The lymph node is removed and sent to be examined by a histopathologist to determine if the node tests positive for melanoma. The procedure is considered when the Breslow thickness of the melanoma is more than 0.8mm.

Patients may develop lumps in the lymph node regions such as the neck, armpit and groin. This is lymph node metastasis.

Distant metastasis

Melanoma that has spread in the blood steam may grow in any site in the body.

Stage 0 (In Situ)

Find out more

Stage 1

Find out more

Stage 2

Find out more

Stage 3

Find out more

Stage 4

Find out more